Your browser is no longer supported. Please, upgrade your browser.
Settings
HRTX Heron Therapeutics, Inc. daily Stock Chart
HRTX [NASD]
Heron Therapeutics, Inc.
Index- P/E- EPS (ttm)-4.62 Insider Own- Shs Outstand53.79M Perf Week-4.69%
Market Cap820.31M Forward P/E- EPS next Y-2.40 Insider Trans- Shs Float53.60M Perf Month-12.86%
Income-190.00M PEG- EPS next Q-0.93 Inst Own- Short Float25.97% Perf Quarter8.16%
Sales4.90M P/S167.41 EPS this Y-54.80% Inst Trans- Short Ratio15.52 Perf Half Y6.64%
Book/sh1.28 P/B11.91 EPS next Y35.20% ROA-152.20% Target Price31.00 Perf Year-27.07%
Cash/sh2.03 P/C7.51 EPS next 5Y26.70% ROE-451.80% 52W Range12.21 - 21.24 Perf YTD16.41%
Dividend- P/FCF- EPS past 5Y-19.10% ROI-540.90% 52W High-28.20% Beta2.06
Dividend %- Quick Ratio2.70 Sales past 5Y14.60% Gross Margin75.10% 52W Low24.86% ATR0.72
Employees139 Current Ratio2.80 Sales Q/Q- Oper. Margin- RSI (14)44.18 Volatility3.40% 4.33%
OptionableYes Debt/Eq0.41 EPS Q/Q31.80% Profit Margin- Rel Volume0.44 Prev Close15.25
ShortableYes LT Debt/Eq0.36 EarningsAug 14 BMO Payout- Avg Volume896.88K Price15.25
Recom1.80 SMA20-5.06% SMA500.81% SMA2003.84% Volume398,607 Change0.00%
Feb-27-17Initiated Needham Buy $28
Oct-26-16Initiated Aegis Capital Buy
Sep-06-16Resumed Lake Street Buy $45
May-03-16Initiated Cantor Fitzgerald Buy
Dec-10-15Initiated Lake Street Buy $45
Sep-23-15Reiterated Leerink Partners Outperform $38 → $57
Sep-02-15Initiated BofA/Merrill Buy $46
Aug-03-15Reiterated Brean Capital Buy $40 → $45
Jun-30-15Reiterated JMP Securities Mkt Outperform $25 → $33
Jun-19-15Reiterated Leerink Partners Outperform $26 → $38
Aug-07-14Initiated Noble Financial Buy $18
Aug-10-17 08:30AM  Should You Buy Heron Therapeutics (HRTX) Ahead of Earnings Zacks
Aug-09-17 10:31PM  Heron Therapeutics reports 2Q loss Associated Press
04:20PM  Heron Therapeutics Reports Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress Business Wire
04:05PM  Heron Therapeutics Announces Initiation of Phase 3 Program for HTX-011 in Postoperative Pain Following Successful End-of-Phase 2 Meeting with FDA Business Wire
Jul-24-17 04:33PM  ETFs with exposure to Heron Therapeutics, Inc. : July 24, 2017 Capital Cube
Jul-14-17 02:57PM  ETFs with exposure to Heron Therapeutics, Inc. : July 14, 2017 Capital Cube
Jul-07-17 04:01PM  Heron Therapeutics, Inc. Value Analysis (NASDAQ:HRTX) : July 7, 2017 Capital Cube -6.20%
Jul-06-17 09:02AM  Heron Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HRTX-US : July 6, 2017 Capital Cube
Jun-20-17 08:24AM  Heron Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HRTX-US : June 20, 2017 Capital Cube
Jun-09-17 08:40AM  Opioids are ravaging the U.S., but theyre still the best pain drug weve got MarketWatch
May-30-17 03:34PM  Heron Therapeutics to Present at the Jefferies 2017 Healthcare Conference Business Wire -5.02%
May-29-17 08:21AM  Heron Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HRTX-US : May 29, 2017 Capital Cube
May-12-17 05:07PM  Heron Therapeutics, Inc. Value Analysis (NASDAQ:HRTX) : May 12, 2017 Capital Cube
May-11-17 08:58AM  Heron Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HRTX-US : May 11, 2017 Capital Cube
May-10-17 08:18AM  Heron Therapeutics reports 1Q loss Associated Press -8.63%
08:00AM  Heron Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress Business Wire
May-09-17 04:05PM  Heron Therapeutics to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference Business Wire
May-01-17 08:15AM  Blog Coverage Zogenix Announces Completion of Enrollment for the Phase III Trial in Dravet Syndrome Accesswire
Apr-24-17 04:05PM  Heron Therapeutics Appoints Robert E. Hoffman as Chief Financial Officer and Senior Vice President, Finance Business Wire
Apr-17-17 03:30AM  Overcoming Opioids: The quest for less addictive drugs Associated Press
Apr-05-17 08:23AM  Heron Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HRTX-US : April 5, 2017 Capital Cube
08:23AM  Heron Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HRTX-US : April 5, 2017
Apr-03-17 12:25PM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Change in Directors or Principal Officers -6.00%
Mar-28-17 04:27PM  Heron Therapeutics to Present at the 16th Annual Needham Healthcare Conference Business Wire
Mar-23-17 08:05AM  Heron Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HRTX-US : March 23, 2017
Mar-17-17 04:18PM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
Mar-13-17 04:05PM  Heron Therapeutics to Present at the Oppenheimer 27th Annual Healthcare Conference Business Wire
Mar-09-17 07:33AM  Heron Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HRTX-US : March 9, 2017 Capital Cube
07:33AM  Heron Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HRTX-US : March 9, 2017
Mar-01-17 01:04PM  HERON THERAPEUTICS, INC. /DE/ Financials
09:34AM  Heron Therapeutics Inc (HRTX) Sustol To Be Included In Antiemesis Guidelines By NCCN Insider Monkey
09:34AM  Heron Therapeutics Inc (HRTX) Sustol To Be Included In Antiemesis Guidelines By NCCN at Insider Monkey
Feb-28-17 04:05PM  Heron Therapeutics to Present at the 37th Annual Cowen and Company Healthcare Conference Business Wire -5.61%
Feb-27-17 07:28AM  Coverage initiated on Heron Therapeutics by Needham +8.99%
Feb-24-17 08:00AM  Heron Therapeutics Announces Inclusion of SUSTOL® (Granisetron) Extended-Release Injection in NCCN® Antiemesis Guidelines Business Wire
Feb-23-17 06:27PM  Heron Therapeutics reports 4Q loss Associated Press
06:27PM  Heron Therapeutics reports 4Q loss
04:57PM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  Heron Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Recent Corporate Progress Business Wire
Feb-16-17 02:31PM  Acadia Pharmaceuticals Surge Higher Is More Than M&A Rumors at Investopedia
Feb-08-17 04:05PM  Heron Therapeutics to Present at the Leerink Partners 6th Annual Global Healthcare Conference Business Wire
Feb-07-17 05:20PM  LifeSci Capital Initiates Coverage of Heron Therapeutics Accesswire
Jan-31-17 09:25AM  Heron Therapeutics Announces Underwriters Exercise in Full of Option to Purchase Additional Shares Business Wire
Jan-24-17 09:20AM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
Jan-20-17 08:47AM  Heron Therapeutics Launches $150M Public Offering at Investopedia
Jan-19-17 06:30AM  Heron Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock Business Wire +8.20%
Jan-18-17 04:25PM  Heron Therapeutics Announces Proposed Public Offering of Common Stock Business Wire
Jan-12-17 08:30AM  Heron Announces Submission of CINVANTI NDA for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Business Wire
Jan-05-17 04:05PM  Heron Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference Business Wire -9.06%
08:30AM  Heron Therapeutics Inc Corporate Update Call scheduled for 8:30 am ET today
Jan-04-17 04:16PM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
04:05PM  Heron Therapeutics Establishes Synergy of Bupivacaine and Meloxicam with HTX-011 for Prevention of Post-Operative Pain in Phase 2 Clinical Studies Business Wire
04:05PM  Heron Therapeutics Announces Positive Topline Results From Phase 2 Clinical Trial of HTX-011 in Abdominoplasty Business Wire
Dec-20-16 03:19PM  What Smart Money Thinks about Echo Global Logistics, Inc. (ECHO)? at Insider Monkey
Dec-12-16 11:13AM  Is Heron Therapeutics Inc (HRTX) a Good Stock To Buy? at Insider Monkey -5.03%
Nov-29-16 11:00AM  Susan G. Komen® Joins Forces With Heron Therapeutics to Raise Awareness of the Supportive Care Needs of Patients With Breast Cancer Business Wire
Nov-28-16 02:20PM  Heron Therapeutics, Inc. :HRTX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 -5.00%
01:47PM  How one investor is playing Heron
Nov-08-16 04:24PM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:06PM  Heron Therapeutics reports 3Q loss
04:01PM  Heron Therapeutics Reports Financial Results for the Three and Nine Months Ended September 30, 2016 and Recent Corporate Progress Business Wire
Oct-20-16 07:23AM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
Oct-04-16 12:30PM  Brean Capital Sees A $300 Million Opportunity For Heron Therapeutics New Drug Launch
Oct-03-16 12:59PM  Heres Why TASER International, Heron Therapeutics and Three Other Stocks Are Trading Lower on Monday at Insider Monkey
Sep-30-16 05:18PM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
Sep-13-16 03:20PM  Heron Therapeutics, Inc. :HRTX-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016
Sep-08-16 09:00AM  Heron Therapeutics Announces Presentations of Results from Phase 2 Clinical Trial of HTX-011 in Hernia Repair at PAINWeek® 2016 Business Wire
Sep-06-16 12:37PM  Here's Why Investors Should Steer Clear of Opioids
Aug-29-16 08:00AM  Heron Therapeutics Announces Poster Presentations of Data from Phase 2 Clinical Program for HTX-011 at PAINWeek® 2016 Business Wire
Aug-15-16 02:44PM  Beyond SUSTOL: Why Heron (HRTX) is a Great Biotech Stock to Buy
Aug-12-16 07:01AM  Biotech Stock Mailbag: Heron, Acadia, Exact Sciences, Sarepta
Aug-11-16 08:14AM  Bulls target upside in Heron Therapeutics
Aug-10-16 04:04PM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
11:05AM  [$$] FDA Approves Heron Therapeutics's Sustol at The Wall Street Journal
09:03AM  Heron Therapeutics shares rise 18% in pre-market trade after company said treatment was approved by FDA at MarketWatch
09:00AM  Heron Therapeutics Inc U.S. FDA Approval of SUSTOL Extended-Release Injection Call scheduled for 9:00 am ET today
08:39AM  FDA approves Heron's therapy for chemotherapy-induced nausea Reuters
08:30AM  Heron Therapeutics Announces U.S. FDA Approval of SUSTOL® (granisetron) Extended-Release Injection for the Prevention of Chemotherapy-Induced Nausea and Vomiting Business Wire
Aug-08-16 04:43PM  Heron Therapeutics reports 2Q loss
04:13PM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:01PM  Heron Therapeutics Reports Second Quarter 2016 Financial Results and Recent Corporate Progress Business Wire
Aug-05-16 09:30AM  The Zacks Analyst Blog Highlights: Aratana Therapeutics, Dynavax Technologies, Heron Therapeutics and La Jolla Pharmaceutical
Aug-04-16 10:33AM  Drug Stocks' Earnings to Watch on Aug 5: PETX, DVAX & More
Aug-02-16 12:36PM  Whats In The Latest Heron Therapeutics Inc (HRTX) Data? at Insider Monkey +7.69%
08:00AM  Heron Therapeutics Enters into Loan Agreement for Up to $100 Million Business Wire
Aug-01-16 06:14AM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:00AM  Heron Therapeutics Reports Positive Top-Line Results from Phase 2 Studies of HTX-011 for Management of Post-Operative Pain Business Wire
Jul-08-16 06:58AM  Biotech Stock Mailbag: Heron, Exelixis
Jun-22-16 04:16PM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
08:00AM  Heron Therapeutics Announces Appointment of Christian Waage to Board of Directors Business Wire
Jun-15-16 08:00AM  Heron Therapeutics to Present at the JMP Securities Life Sciences Conference Business Wire
Jun-11-16 03:04PM  Healthcare-Focused Broadfin Capitals Notable Moves Include Cardiovascular Systems, Nevro Corp & Others at Insider Monkey
Jun-01-16 05:02PM  Heron Therapeutics, Inc. :HRTX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016
May-18-16 12:22PM  Heron and the Never-Ending FDA Drug Review at TheStreet
May-16-16 03:09PM  Here's Why Trevena Stock Dropped 18% Today at Motley Fool +5.57%
May-05-16 04:51PM  Heron Therapeutics reports 1Q loss -5.76%
04:20PM  HERON THERAPEUTICS, INC. /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:01PM  Heron Therapeutics Announces First Quarter 2016 Financial Results and Recent Corporate Progress Business Wire
Apr-23-16 03:17PM  This Was the Best Performing Healthcare ETF Last Week at Motley Fool
Apr-19-16 11:15AM  Why Are Investors Piling Into These 5 Surging Stocks? at Insider Monkey +5.07%
Heron Therapeutics, Inc., a biotechnology company, develops products to address unmet medical needs using its proprietary Biochronomer polymer-based drug delivery platform in the United States. Its drug delivery platform is designed to enhance the therapeutic profile of injectable pharmaceuticals. The company's lead product candidate includes SUSTOL (granisetron injection, extended release), which is in Phase III clinical trial for the prevention of acute- and delayed-onset chemotherapy-induced nausea and vomiting. It is also developing HTX-011 that is in Phase I clinical trial for the management of post-operative pain; HTX-019, an injectable neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting; and HTX-003, a formulation of buprenorphine for the management of chronic pain and opioid addiction. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MANHARD KIMBERLYExecutive VP, Drug DevelopmentApr 24Option Exercise8.9921,542193,64321,542Apr 24 08:58 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentApr 24Sale15.3321,542330,2630Apr 24 08:58 PM
POYHONEN JOHNDirectorJan 19Buy12.2010,000122,00010,000Jan 23 04:29 PM
TANG KEVIN CDirectorJan 19Buy12.202,459,01629,999,9958,332,907Jan 23 04:03 PM